Medicalgorithmics S.A. (MDG.WA)
PLN 25.25
(2.02%)
PLN 25.25
(2.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 182 Thousand | 6.33 Million | -6.47 Million | -3.95 Million | 13.49 Million | 44.23 Million |
| Net Income | -578 Thousand | -30.4 Million | -180.63 Million | -27.67 Million | -299 Thousand | 18.94 Million |
| Depreciation & Amortization | 2.36 Million | 4.22 Million | 17.53 Million | 15.89 Million | 18.71 Million | 11.57 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.88 Million | -31.76 Million | -13.93 Million | 20.46 Million | -2.78 Million | 5.21 Million |
| Other non-cash items | 281 Thousand | 64.27 Million | 170.56 Million | -12.63 Million | -2.13 Million | 8.49 Million |
| Investing Cash Flow | 1.96 Million | -1.81 Million | -15.77 Million | -5 Million | -2.79 Million | 2.4 Million |
| Investments in PPE | -11.31 Million | -12.37 Million | -15.87 Million | -5 Million | -8.74 Million | -6.43 Million |
| Acquisitions | - | -9.39 Million | - | - | - | -167 Thousand |
| Investment purchases | - | -9.39 Million | - | - | - | 5.05 Million |
| Sales/Maturities of investments | 13.28 Million | 19.95 Million | 103 Thousand | - | 5.95 Million | 9 Million |
| Other Investing Activities | 2.45 Million | 9.39 Million | -5.86 Million | -4.59 Million | 127 Thousand | -5.05 Million |
| Financing Cash Flow | -2.8 Million | 9.97 Million | 17.72 Million | 14 Million | -59.74 Million | -18.98 Million |
| Debt repayment | -9000.00 | -1.47 Million | -136 Thousand | -12.85 Million | -58.03 Million | -1.63 Million |
| Dividends payments | - | - | - | - | - | -5.12 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 13.87 Million | 11.44 Million | 12.57 Million | - | - |
| Other Financing Activities | -1.55 Million | -2.41 Million | 6.41 Million | 14.28 Million | -1.71 Million | -12.22 Million |
| Accounts receivables | -4.73 Million | -36.29 Million | -2.88 Million | 6.1 Million | -1.66 Million | 633 Thousand |
| Accounts payables | 4.73 Million | -51 Thousand | 4.97 Million | 2.3 Million | -1.28 Million | 3.08 Million |
| Inventory | -550 Thousand | -1.63 Million | -11 Thousand | -288 Thousand | 36 Thousand | - |
| Other working capital | -1.33 Million | 6.21 Million | -16.01 Million | 12.34 Million | 133 Thousand | 1.48 Million |
| Cash at beginning of period | 26.16 Million | 11.66 Million | 16.19 Million | 11.15 Million | 60.18 Million | 32.53 Million |
| Cash at end of period | 25.5 Million | 26.16 Million | 11.66 Million | 16.19 Million | 11.15 Million | 60.18 Million |
| Capital Expenditure | -11.31 Million | -12.37 Million | -15.87 Million | -5 Million | -8.74 Million | -6.43 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -664 Thousand | 14.49 Million | -4.53 Million | 5.04 Million | -49.03 Million | 27.65 Million |
| Free Cash Flow | -11.13 Million | -6.04 Million | -22.35 Million | -8.96 Million | 4.75 Million | 37.79 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.31 Million | -4 Million | -578 Thousand | -676 Thousand | -178 Thousand | -1.24 Million |
| Depreciation & Amortization | 884 Thousand | 481 Thousand | 2.36 Million | 324 Thousand | 701 Thousand | 474 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.65 Million | -2.27 Million | -1.88 Million | 994 Thousand | -1.74 Million | 2.9 Million |
| Other non-cash items | 464 Thousand | 327 Thousand | 281 Thousand | -1.31 Million | 1.61 Million | -4.7 Million |
| Investing Cash Flow | -2.35 Million | -2.11 Million | 1.96 Million | -4.01 Million | -2.56 Million | 10.64 Million |
| Investments in PPE | -24 Thousand | -74 Thousand | -11.31 Million | -4.01 Million | -2.56 Million | -2.63 Million |
| Acquisitions | - | - | - | -13.28 Million | - | 13.28 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 13.28 Million | 13.28 Million | - | - |
| Other Investing Activities | -2.33 Million | -2.03 Million | 2.45 Million | -3.88 Million | -2.41 Million | 10.75 Million |
| Financing Cash Flow | -1.12 Million | -1.54 Million | -2.8 Million | 364 Thousand | -1.28 Million | -13.85 Million |
| Debt repayment | -1.12 Million | -1.54 Million | -9000.00 | -2.84 Million | -2.84 Million | -16 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -349 Thousand | -357 Thousand | -1.55 Million | -2.06 Million | 1.56 Million | -13.83 Million |
| Accounts receivables | 2.31 Million | -1.86 Million | -4.73 Million | -3.49 Million | -3.21 Million | 3.64 Million |
| Accounts payables | -151 Thousand | 131 Thousand | 4.73 Million | 3.49 Million | 485 Thousand | -2.57 Million |
| Inventory | -379 Thousand | -897 Thousand | -550 Thousand | 2.17 Million | -1.31 Million | -115 Thousand |
| Other working capital | -285 Thousand | 491 Thousand | -1.33 Million | -1.17 Million | 2.29 Million | 1.94 Million |
| Cash at beginning of period | 16.37 Million | 25.5 Million | 26.16 Million | 29.82 Million | 33.27 Million | 39.05 Million |
| Cash at end of period | 10.57 Million | 16.37 Million | 25.5 Million | 25.5 Million | 29.82 Million | 33.27 Million |
| Capital Expenditure | -24 Thousand | -74 Thousand | -11.31 Million | -4.01 Million | -2.56 Million | -2.63 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.79 Million | -9.12 Million | -664 Thousand | -4.32 Million | -3.45 Million | -5.78 Million |
| Free Cash Flow | -2.34 Million | -5.54 Million | -11.13 Million | -4.68 Million | -2.16 Million | -5.21 Million |
0JTZ
DEVIT
T
SAGGF
002364
OASISEC